[1]
J. H. Kim, W. Lee, T. N. Kim, J. K. Nam, T. H. Kim, and K. S. Lee, “Clinical outcomes of the sequential use of pazopanib followed by everolimus for the treatment of metastatic renal cell carcinoma: A multicentre study in Korea”, CUAJ, vol. 12, no. 1, pp. E15–20, Nov. 2017.